Schedule 13G ownership disclosure

Artiva Biotherapeutics, Inc.

Security class unavailable · CUSIP: 04317A107

Event date: 2024-07-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,171,250
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-084914
Form type
SC 13G
Filer
5AM Ventures VI, L.P.
CIK
CIK 1753037
Filed
Aug 01, 2024
Reporting period
Jul 22, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub